Barry Fish, MD
Obstetrics · Fairlawn, OHNPI 1437154770
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,000 of the $1,644 with a category attached, or 60.8%. Applied Medical Resources Corporation accounts for 66.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $1,170 and has fallen 90.3% since, to $113 in 2025.
Across 30 payments — averaging $54.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$1K
- Hologic Sales And Service, LLC$139
- AbbVie$72
- Organon$69
- Optumhealth Care Solutions, LLC$60
- Therapeuticsmd, Inc.$54
- plus $160 from 8 others
What the payments were for
- Speaking & faculty fees$1,00061%
- Food & beverage$64339%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 2 | $1,091 |
| Hologic Sales And Service, LLC | 7 | $139 |
| AbbVie | 4 | $72 |
| Organon | 1 | $69 |
| Optumhealth Care Solutions, LLC | 3 | $60 |
| Therapeuticsmd, Inc. | 3 | $54 |
| Exeltis, USA Inc. | 2 | $36 |
| Virtus Pharmaceuticals LLC | 2 | $32 |
| Sage Therapeutics, LLC | 1 | $17 |
| Lupin Inc. | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Alydia Health | 1 | $13 |
| Duchesnay USA Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$1,000
How this compares
$1,644 in reported general payments places this provider in the 70th percentile of 39 obstetrics providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 60 | $2,919 |
| YuvafemEstradiol | 12 | $2,128 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $1,291 |
| ProgesteroneProgesterone, Micronized | 33 | $711 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $443 |
| Alendronate Sodium | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Fairlawn
- Michelle BirkenholzDublin$30K
- Rebecca FlycktCleveland$10K
- Jennifer MittlesteadDayton$9K
- Bonnie CorleyGrove City$9K
- Elizabeth VenardCincinnati$6K
- Chanel SinclairGrandview Heights$3K
- Blaise MilburnSteubenville$2K
- Rebekah McClainDublin$2K
- Melinda SmithPoland$2K
- Amanda WhittakerToledo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.